XTL BIOPHARMACEUTICALS LTD (XTLB)
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Address
XTL BIOPHARMACEUTICALS LTD
NEW YORK, NY 10016
Founded
1993
Number of Employees
8
Website
http://www.xtlbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)